Screening, assessment and management of type 2 diabetes mellitus in children and adolescents: Australasian Paediatric Endocrine Group guidelines

Simple item page
dc.contributor.authorPeña, A.S.
dc.contributor.authorCurran, J.A.
dc.contributor.authorFuery, M.
dc.contributor.authorGeorge, C.
dc.contributor.authorJefferies, C.A.
dc.contributor.authorLobley, K.
dc.contributor.authorLudwig, K.
dc.contributor.authorMaguire, A.M.
dc.contributor.authorPapadimos, E.
dc.contributor.authorPeters, A.
dc.contributor.authorSellars, F.
dc.contributor.authorSpeight, J.
dc.contributor.authorTitmuss, A.
dc.contributor.authorWilson, D.
dc.contributor.authorWong, J.
dc.contributor.authorWorth, C.
dc.contributor.authorDahiya, R.
dc.date.issued2020
dc.description.abstractINTRODUCTION:The incidence of type 2 diabetes mellitus has increased in children and adolescents due largely to the obesity epidemic, particularly in high risk ethnic groups. β-Cell function declines faster and diabetes complications develop earlier in paediatric type 2 diabetes compared with adult-onset type 2 diabetes. There are no consensus guidelines in Australasia for assessment and management of type 2 diabetes in paediatric populations and health professionals have had to refer to adult guidelines. Recent international paediatric guidelines did not address adaptations to care for patients from Indigenous backgrounds. MAIN RECOMMENDATIONS:This guideline provides advice on paediatric type 2 diabetes in relation to screening, diagnosis, diabetes education, monitoring including targets, multicomponent healthy lifestyle, pharmacotherapy, assessment and management of complications and comorbidities, and transition. There is also a dedicated section on considerations of care for children and adolescents from Indigenous background in Australia and New Zealand. CHANGES IN MANAGEMENT AS A RESULT OF THE GUIDELINES:Published international guidelines currently exist, but the challenges and specifics to care for children and adolescents with type 2 diabetes which should apply to Australasia have not been addressed to date. These include: recommendations regarding care of children and adolescents from Indigenous backgrounds in Australia and New Zealand including screening and management; tighter diabetes targets (glycated haemoglobin, ≤ 48 mmol/mol [≤ 6.5%]) for all children and adolescents; considering the use of newer medications approved for adults with type 2 diabetes under the guidance of a paediatric endocrinologist; and the need to transition adolescents with type 2 diabetes to a diabetes multidisciplinary care team including an adult endocrinologist for their ongoing care.
dc.description.statementofresponsibilityAlexia S Peña, Jacqueline A Curran, Michelle Fuery, Catherine George, Craig A Jefferies, Kristine Lobley, Karissa Ludwig, Ann M Maguire, Emily Papadimos, Aimee Peters, Fiona Sellars, Jane Speight, Angela Titmuss, Dyanne Wilson, Jencia Wong, Caroline Worth, Rachana Dahiya
dc.identifier.citationMedical Journal of Australia, 2020; 213(1):30-43
dc.identifier.doi10.5694/mja2.50666
dc.identifier.issn0025-729X
dc.identifier.issn1326-5377
dc.identifier.orcidPeña, A.S. [0000-0002-6834-4876]
dc.identifier.urihttp://hdl.handle.net/2440/129319
dc.language.isoen
dc.publisherWiley
dc.rights© 2020 AMPCo Pty Ltd
dc.source.urihttps://doi.org/10.5694/mja2.50666
dc.subjectDiabetes mellitus, type 2
dc.subjectChildhood diseases
dc.subjectAdolescence
dc.subjectSocial determinants of health
dc.subjectIndigenous health
dc.titleScreening, assessment and management of type 2 diabetes mellitus in children and adolescents: Australasian Paediatric Endocrine Group guidelines
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Paediatrics publications